Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Hochhaus, Andreas, Gambacorti-Passerini, Carlo, Abboud, Camille, Gjertsen, Bjørn Tore, Brümmendorf, Tim H., Smith, B. Douglas, Ernst, Thomas, Giraldo-Castellano, Pilar, Olsson-Strömberg, Ulla, Saussele, Susanne, Bardy-Bouxin, Nathalie, Viqueira, Andrea, Leip, Eric, Russell-Smith, T. Alexander, Leone, Jocelyn, Rosti, Gianantonio, Watts, Justin, Giles, Francis J.
Published in Leukemia (01.08.2020)
Published in Leukemia (01.08.2020)
Get full text
Journal Article
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
Kuendgen, A., Nomdedeu, M., Tuechler, H., Garcia-Manero, G., Komrokji, R. S., Sekeres, M. A., Della Porta, M. G., Cazzola, M., DeZern, A. E., Roboz, G. J., Steensma, D. P., Van de Loosdrecht, A. A., Schlenk, R. F., Grau, J., Calvo, X., Blum, S., Pereira, A., Valent, P., Costa, D., Giagounidis, A., Xicoy, B., Döhner, H., Platzbecker, U., Pedro, C., Lübbert, M., Oiartzabal, I., Díez-Campelo, M., Cedena, M. T., Machherndl-Spandl, S., López-Pavía, M., Baldus, C. D., Martinez-de-Sola, M., Stauder, R., Merchan, B., List, A., Ganster, C., Schroeder, T., Voso, M. T., Pfeilstöcker, M., Sill, H., Hildebrandt, B., Esteve, J., Nomdedeu, B., Cobo, F., Haas, R., Sole, F., Germing, U., Greenberg, P. L., Haase, D., Sanz, G.
Published in Leukemia (01.03.2021)
Published in Leukemia (01.03.2021)
Get full text
Journal Article
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium
Zeidan, A M, Al Ali, N, Barnard, J, Padron, E, Lancet, J E, Sekeres, M A, Steensma, D P, DeZern, A, Roboz, G, Jabbour, E, Garcia-Manero, G, List, A, Komrokji, R
Published in Leukemia (01.06.2017)
Published in Leukemia (01.06.2017)
Get full text
Journal Article
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides
Zeidan, A M, Sekeres, M A, Garcia-Manero, G, Steensma, D P, Zell, K, Barnard, J, Ali, N A, Zimmerman, C, Roboz, G, DeZern, A, Nazha, A, Jabbour, E, Kantarjian, H, Gore, S D, Maciejewski, J P, List, A, Komrokji, R
Published in Leukemia (01.03.2016)
Published in Leukemia (01.03.2016)
Get full text
Journal Article
Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis
Krez, A., Lane, J., Heilbronner, A., Park-Min, K.-H., Kaneko, K., Pannellini, T., Mintz, D., Hansen, D., McMahon, D.J., Kirou, K.A., Roboz, G., Desai, P., Bockman, R.S., Stein, E.M.
Published in Osteoporosis international (01.10.2021)
Published in Osteoporosis international (01.10.2021)
Get full text
Journal Article
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
Roboz, Gail J., Dias, Sergio, Lam, George, Lane, William J., Soignet, Steven L., Warrell, Raymond P., Rafii, Shahin
Published in Blood (15.08.2000)
Published in Blood (15.08.2000)
Get full text
Journal Article
Phase 1 study of PTK787 ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
ROBOZ, G. J, GILES, F. J, LAURENT, D, FELDMAN, E. J, LIST, A. F, CORTES, J. E, CARLIN, R, KOWALSKI, M, BILIC, S, MASSON, E, ROSAMILIA, M, SCHUSTER, M. W
Published in Leukemia (01.06.2006)
Published in Leukemia (01.06.2006)
Get full text
Journal Article
What are RBC-transfusion-dependence and -independence?
Gale, R.P, Barosi, G, Barbui, T, Cervantes, F, Dohner, K, Dupriez, B, Gupta, V, Harrison, C, Hoffman, R, Kiladjian, J.-J, Mesa, R, Mc Mullin, M.F, Passamonti, F, Ribrag, V, Roboz, G, Saglio, G, Vannucchi, A, Verstovsek, S
Published in Leukemia research (01.01.2011)
Published in Leukemia research (01.01.2011)
Get full text
Journal Article
P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI‐01 TRIAL OF UCART22, AN ANTI‐CD22 ALLOGENEIC CAR‐T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B‐CELL ALL
Jain, N., Roboz, G., Konopleva, M., Liu, H., Schiller, G., Jabbour, E., Desai, P., Whitfield, D., Haider, A., Zernovak, O., Frattini, M., Brownstein, C., Larson, R.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P584: OVERALL SURVIVAL WITH INTENSIVE CHEMOTHERAPY (IC) VS NON‐IC IN PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AML FROM THE CONNECT® MYELOID DISEASE REGISTRY INELIGIBLE FOR RANDOMIZED CLINICAL TRIALS (RCT)
Erba, H., Pollyea, D., Sekeres, M., Garcia‐Manero, G., Seiter, K., DeGutis, I., Kiselev, P., McBride, A., Yu, E., Roboz, G.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
Feldman, E J, Cortes, J, DeAngelo, D J, Holyoake, T, Simonsson, B, O'Brien, S G, Reiffers, J, Turner, A R, Roboz, G J, Lipton, J H, Maloisel, F, Colombat, P, Martinelli, G, Nielsen, J L, Petersdorf, S, Guilhot, F, Barker, J, Kirschmeier, P, Frank, E, Statkevich, P, Zhu, Y, Loechner, S, List, A
Published in Leukemia (01.09.2008)
Published in Leukemia (01.09.2008)
Get full text
Journal Article
A Validation of a Post-Hypomethylating Agent Failure (HMAF) Prognostic Model in MDS Patients Treated with Rigosertib Versus Best Supportive Care (BSC)
Nazha, A, Sekeres, M, Komrokji, R, Steensma, D, Kantarjian, H, Roboz, G, Fenaux, P, Prebet, T, Azarnia, N, Zbyszewski, P, Fruchtman, S, Santini, V, Silverman, L, Platzbecker, U, Garcia-Manero, G
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
Zong, H, Sen, S, Zhang, G, Mu, C, Albayati, Z F, Gorenstein, D G, Liu, X, Ferrari, M, Crooks, P A, Roboz, G J, Shen, H, Guzman, M L
Published in Leukemia (01.07.2016)
Published in Leukemia (01.07.2016)
Get full text
Journal Article
P555: A PHASE 1B/2 STUDY OF THE CD123‐TARGETING ANTIBODY‐DRUG CONJUGATE PIVEKIMAB SUNIRINE (IMGN632) IN COMBINATION WITH VENETOCLAX (VEN) AND AZACITIDINE (AZA) FOR PATIENTS WITH CD123‐POSITIVE AML
Daver, N. G., Montesinos, P., Aribi, A., Martinelli, G., Altman, J., Roboz, G., Wang, E. S., Burke, P. W., Jeyakumar, D., Walter, R. B., DeAngelo, D. J., Erba, H. P., Advani, A., Gastaud, L., Thomas, X., Todisco, E., Pemmaraju, N., Mendez, L., Fuente, A., Gaidano, G., Curti, A., Boissel, N., Recher, C., Schliemann, C., Vyas, P., Sloss, C. M., Wang, J., Malcolm, K. A., Zweidler‐McKay, P. A., Sweet, K. L.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
320 RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM
Komrokii, R, Zeidan, A, Al Ali, N, Padron, E, Lancet, J, Steensma, D, Dezern, A, Roboz, G, Jabbour, E, Sekeres, M, Garcia-Manero, G, List, A
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?
Silverman, L.R, Fenaux, P, Al-Kali, A, Baer, M.R, Sekeres, M, Roboz, G, Gaidano, G, Scott, B, Greenberg, P, Platzbecker, U, Steensma, D.P, Kambhampati, S, Kreuzer, K.A, Godley, L, Collins, R, Atallah, E, Navada, S.C, Azarnia, N, Garcia-Manero, G
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
249 CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
Steensma, D, Abedi, M, Bejar, R, Cogle, C, Foucar, K, Garcia-Manero, G, George, T, Grinblatt, D, Komrokji, R, Maciejewski, J, Pollyea, D, Roboz, G, Savona, M, Scott, B, Sekeres, M, Thompson, M, Sugrue, M, Swern, A, Nifenecker, M, Erba, H
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
112 RANDOMIZED PHASE III STUDY OF IV RIGOSERTIB VERSUS BEST SUPPORTIVE CARE (BSC) IN PATIENTS WITH HIGHER-RISK MDS (HR-MDS) AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS)
Garcia-Manero, G, Fenaux, P, Al-Kali, A, Baer, M.R, Sekeres, M, Roboz, G, Gaidano, G, Scott, B, Greenberg, P, Platzbecker, U, Steensma, D.P, Kambhampati, S, Kreuzer, K.A, Godley, L, Collins, R, Atallah, E, Azarnia, N, Petrone, M.E, Snyder, B.R, Maniar, M, Silverman, L.R
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
RBC-transfusion guidelines update
Gale, R.P, Barosi, G, Barbui, T, Cervantes, F, Dohner, K, Dupriez, B, Gupta, V, Harrison, C, Hoffman, R, Kiladjian, J.J, Mesa, R, Mc Mullin, M.F, Passamonti, F, Ribrag, V, Roboz, G, Saglio, G, Vannucchi, A, Verstovsek, S
Published in Leukemia research (01.05.2012)
Published in Leukemia research (01.05.2012)
Get full text
Journal Article
P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG‐TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML‐001 TRIAL OF ORAL AZACITIDINE
Wei, A. H., Döhner, H., Sayar, H., Ravandi, F., Montesinos, P., Dombret, H., Selleslag, D., Porkka, K., Jang, J.‐H., Skikne, B., Beach, C., Prebet, T., Zhang, G., Risueño, A., Ugidos Guerrero, M., See, W. L., Menezes, D., Roboz, G. J.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article